TNF and early-onset autosomal dominant Alzheimer disease: In contrast to poly I:C- and TNFα-treated human astrocytes, we did not detect any significant correlation between gene expression changes of poly I:C- or TNFα-treated mouse astrocytes and Alzheimer’s disease or multiple sclerosis patients, highlighting species-dependent gene signatures in astrocyte reactivity (Fig. 8a).